XOSPATA Presentation
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients (077-0621-PM) PRESENTER Catherine Lai, M.D., M.P.H.
RSVP by July 15 To: https://astellas.virtualspeakercast.net/Registration/index/275 Phone: 973-930-3192 Email: melba.vasquez@astellas.com Register at https://astellas.virtualspeakercast.net/Registration/index/275 A confirmation will then be sent to you with the program web link and call-in number
|
|